All results / Stories / Amy Stulick


Medtronic Launches Smart Insulin Pen Device

Medical device giant Medtonic has launched InPen, the first FDA-cleared smart insulin pen for diabetes patients needing multiple daily injections.

Valley Hospital Staff Receive COVID Vaccine

Hospitals in the Valley region have started administering the COVID-19 vaccine made by Pfizer Inc.

Amgen Partnerships Provide Positive News

COVID and asthma clinical trials get green lights.

Amgen Inc.’s partnerships have delivered a flurry of positive news

Medical Supply Company Settles Medicare Fraud Claims

Valley Home Medical Supply Inc. in Canoga Park paid a $565,873 settlement after allegations arose that the company defrauded the federal government's Medicare and Tricare programs.

MannKind Misses Quarterly Estimate But Afrezza Sales Increase

MannKind Corp. missed third-quarter earnings estimates by 1 cent, but enjoyed a net revenue increase for its flagship drug, inhalable insulin Afrezza.

AIDS Healthcare Foundation Protests Amgen Pricing for Orphan Drugs

The AIDS Healthcare Foundation in Los Angeles staged a socially distant protest at Amgen headquarters in Thousand Oaks in response to the biotech giant’s refusal to sell orphan drugs to nonprofit entities at a reduced price.

Calabasas HR Firm's Partnership Targets Construction Industry

Human resources management provider Arcoro has partnered with Sage Construction and Real Estate.

Ventura Lab Hosts Biome Conference

Malibu Microbiome Meeting followed with live Q&A.

Progenabiome in Ventura shared its Malibu Microbiome Meeting earlier this month,

For Drug Modeler, French Connection Pays Off

Quarterly report validates Simulations Plus’ acquisition of Lixoft earlier in the year.

Simulations Plus bought French medical software company Lixoft in April, despite a pandemic that hampered in-person communication.

Valley Hospitals Grapple With COVID-19 Surge

The number of available intensive care unit beds has plummeted in Los Angeles County, with only 92 ICU beds available countywide.

MannKind Buys QrumPharma for $3.5 Million

MannKind Corp. announced it has acquired Pennsylvania-based QrumPharma Inc. for $3.5 million in cash and more than 3 million shares of its common stock.

Amgen Ends Drug Collaboration With Cytokinetics

Amgen Inc. has terminated its collaboration with Bay area startup Cytokinetics.

Local Biotech Makes Deal with Giant

Agoura Hills biotech company A2 Biotherapeutics on Wednesday announced it has entered into a collaboration agreement with pharma giant Merck to further develop its cancer therapies.

Westlake Village BioPartners Debuts Funds With $500 Million

Westlake Village BioPartners has announced two new funds totaling $500 million to invest in life science startups and construct lab facilities for them.

Eli Lilly Asks FDA to Fast Track Drug

Amgen could manufacture treatment for COVID-19.

If Indianapolis-based pharma giant Eli Lilly & Co. is granted an emergency use authorization for its leading COVID-19 antibody candidate, Amgen Inc. will have to fulfill its side of a collaboration agreement very soon.

Westlake Bio, Alexandria Team on Lab Buildout

BIOTECH: VC firm to invest in startups that become tenants.

Two real estate deals have put the Conejo Valley’s biotech hub on the fast-track to expansion.

Lief Labs Sales Nearly Double in Pandemic

Valencia supplement maker meets demand for immune-enhancing and weight-loss treatments.

Valencia’s Leif Labs upgrades to a 112,000-square-foot facility.

Caulipower

Caulipower

Gluten-free food producer Caulipower has not felt the sting that others in the food industry have suffered during the pandemic, using its nimbleness to ensure supermarket shelves are stocked with its cauliflower-centric products.

Staffing’s Virtual Future From Interview to Job

LIST: Employment firms and clients find tech makes hiring flexible.

Employment firms see mixed reactions from clients in terms of hiring in the midst of a pandemic, with the impact varying based on the industry.

Buying into Market Dip to Rebalance Portfolios

One of Jason Sands’ clients asked how he could help others financially during tough times.

Wealth manager Jason Sands sought to keep clients on track for their long-term goals during the year of crisis, while also meeting short-term needs.